Clinical Trial Update: Pilot Trial of Transnasal Nicotine in Parkinson Disease [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial evaluated transnasal nicotine in Parkinson disease and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• transnasal nicotine (nicotine)

Snippet

Sponsor: El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED